Medical specimen tracking market seen reaching $1.64 billion by 2030

The global medical specimen tracking systems market is expected to grow from $1.23 billion in 2026 to $1.64 billion by 2030, driven by precision medicine, more diagnostic testing and broader lab automation. North America led the market in 2025 as providers increased demand for traceable, error-reducing sample management tools.

Why it matters: - Medical specimen tracking systems help labs and diagnostic centers keep biological samples traceable from collection to storage. - Better tracking reduces errors, supports specimen integrity and improves diagnostic reliability. - The market is expanding as healthcare shifts toward precision medicine and higher testing volumes.

What happened: - The Business Research Company released its Medical Specimen Tracking Systems Global Market Report 2026, covering market size, trends and forecasts for 2026-2035. - The report estimates the market will rise from $1.15 billion in 2025 to $1.23 billion in 2026. - The report forecasts the market will reach $1.64 billion by 2030. - North America was the largest regional market in 2025. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa. - A free sample report is available here. - The full report is available here.

The details: - Medical specimen tracking systems are digital platforms that monitor the full lifecycle of samples such as blood, tissue and urine. - The systems use barcodes, RFID and cloud-based software. - Core functions include specimen collection, labeling, transport, testing and storage. - The report links past growth to barcoding adoption, stronger traceability requirements, automation demand, tighter regulation and laboratory expansion. - The report ties future growth to AI and machine learning, cloud-based solutions, biobanking investment, IoT-enabled automation and precision diagnostics. - Expected trends include automated specimen handling, real-time tracking, LIMS integration, remote access, mobile monitoring and workflow optimization. - Precision medicine is a major demand driver because it depends on accurate, fast handling of biological samples for targeted treatment decisions. - The Personalized Medicine Coalition reported in February 2024 that the FDA approved 16 new personalized treatments for rare diseases in 2023, up from six in 2022. - Rising diagnostic testing volumes are also pushing demand for specimen tracking. - The NHS reported in November 2023 that England conducted 45.0 million imaging tests in the year ending March 2023, up 2.2% from 44.0 million the year before.

Between the lines: - The market outlook points to a shift from basic sample logging toward software-driven lab operations. - AI, cloud tools and connected devices are becoming part of a broader push to make laboratories faster and more error-resistant. - Precision medicine and diagnostic growth suggest specimen tracking is becoming a core infrastructure layer, not just a back-office function.

What's next: - The market is expected to keep growing through 2030 as labs invest in automation and digital tracking. - Broader adoption of LIMS integration, mobile access and real-time monitoring should shape product development. - The Business Research Company says its 2026 reports include market attractiveness scoring, TAM analysis, company scoring matrices, Excel-based forecasting dashboards and market hotspot graphics. - The company lists Saumya Sahay as a contact for its report materials, with additional contact details and social links provided in the release.